Stem cells to the retina: METTL3 at the crossroads of RNA marks and gene control
Official title: Stem Cells to Retina: METTL3 at the Nexus of the Epitranscriptome andEpigenome
Funded at Veterans Health Administration · NIH-11410963 · Data updated 2026-11-12
Aims to unlock new ways to repair vision by guiding stem cells to become retinal cells and exploring RNA biology in eye diseases that affect veterans.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Veterans Health Administration NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | October 1, 2026 |
| Project end | September 30, 2030 |
| Funding year | 2027 |
| NIH project number | 1I01RD001109-01A1 |
| Project ID | NIH-11410963 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with age-related macular degeneration, diabetic retinopathy, glaucoma, or combat-related eye trauma who are candidates for retinal cell therapies.
✕Less likely to help
Individuals without degenerative retinal conditions or those not eligible for regenerative therapies may not benefit.
What this research studies
This project focuses on how specific RNA modifications influence the transformation of stem cells into retinal cells, with the goal of enabling new cell-based therapies for vision loss from AMD, diabetic retinopathy, glaucoma, and eye injuries. Researchers will map RNA methylation patterns, study how METTL3 and related factors control retinal cell development, and test strategies to promote regeneration within the eye. The work combines advanced molecular tools and cell biology to identify targets that could improve the survival and function of retinal cells in patients. If successful, the findings could accelerate regenerative approaches to restore sight for veterans and others with degenerative eye conditions.
Why it matters
Potential benefit: If the approach succeeds, patients could benefit from improved or restored vision through regenerative therapies.
How similar studies have gone: Prior work in stem cell differentiation and RNA modification has shown promise, but applying these mechanisms to retinal regeneration is an emerging area.
Where this research is happening
-
Veterans Health Administration
Ann Arbor, United States Active
Researchers
- Principal investigator: Rao, Rajesh C. — Veterans Health Administration
- Study coordinator: Rao, Rajesh C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.